Literature DB >> 9056542

Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages.

J G Sheng1, R E Mrak, W S Griffin.   

Abstract

Activated microglia, overexpressing interleukin-1 (IL-1), and activated astrocytes, overexpressing S100beta, have been implicated in the formation and evolution of tau2-immunoreactive (tau2+) neuritic plaques in Alzheimer disease. In this study, we assessed the role of IL-1alpha+ microglia and S100beta+ astrocytes in the pathogenesis of another cardinal histopathological feature of Alzheimer disease: tau2+ neurofibrillary tangles. Four distinct stages of neurofibrillary tangle formation were identified: neurons with granular perikaryal tau2 immunoreactivity (stage 0); fibrillar neuronal inclusions (stage 1); dense, neuronal soma-filling inclusions (stage 2); and acellular, fibrillar deposits (stage 3, "ghost tangles"). The numbers of tangles in randomly selected fields of parahippocampal cortex from 11 Alzheimer patients correlated with both the numbers of IL-1alpha+ microglia and the numbers of S100beta+ astrocytes in these fields (r = 0.72, p < 0.02; r = 0.73, p = 0.01, respectively). There were progressive increases in frequency of association between tangle stages and both IL-1alpha+ microglia and S100beta+ astrocytes: 48, 56, 67, and 92% of stage 0-3 tangles, respectively, had associated IL-1alpha+ microglia; and 21, 37, 55, and 91% of stage 0-3 tangles had associated S100beta+ astrocytes. This progressive association of activated IL-1alpha+ microglia and activated S100beta+ astrocytes with tau2+ tangle stages suggests a role for glial-neuronal interactions in the degeneration of tangle-bearing neurons in Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9056542

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  67 in total

Review 1.  The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk.

Authors:  W S Griffin; J A Nicoll; L M Grimaldi; J G Sheng; R E Mrak
Journal:  Exp Gerontol       Date:  2000-07       Impact factor: 4.032

2.  Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo.

Authors:  J G Sheng; S G Zhu; R A Jones; W S Griffin; R E Mrak
Journal:  Exp Neurol       Date:  2000-06       Impact factor: 5.330

3.  Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors:  W Sue T Griffin; Steven W Barger
Journal:  US Neurol       Date:  2010

4.  Time dependent alterations of co-localization of S100beta and GFAP in the MPTP-treated mice.

Authors:  T Himeda; Y Watanabe; H Tounai; N Hayakawa; H Kato; T Araki
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

Review 5.  The role of biomarkers in clinical trials for Alzheimer disease.

Authors:  Leon J Thal; Kejal Kantarci; Eric M Reiman; William E Klunk; Michael W Weiner; Henrik Zetterberg; Douglas Galasko; Domenico Praticò; Sue Griffin; Dale Schenk; Eric Siemers
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jan-Mar       Impact factor: 2.703

6.  Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.

Authors:  W S Griffin; J G Sheng; J E McKenzie; M C Royston; S M Gentleman; R A Brumback; L C Cork; M R Del Bigio; G W Roberts; R E Mrak
Journal:  Neurobiol Aging       Date:  1998 Sep-Oct       Impact factor: 4.673

Review 7.  Novel Key Players in the Development of Tau Neuropathology: Focus on the 5-Lipoxygenase.

Authors:  Elisabetta Lauretti; Domenico Praticò
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  IFN-γ promotes τ phosphorylation without affecting mature tangles.

Authors:  Andrew Li; Carolina Ceballos-Diaz; Nadia DiNunno; Yona Levites; Pedro E Cruz; Jada Lewis; Todd E Golde; Paramita Chakrabarty
Journal:  FASEB J       Date:  2015-07-08       Impact factor: 5.191

9.  Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model.

Authors:  Simantini Ghosh; Michael D Wu; Solomon S Shaftel; Stephanos Kyrkanides; Frank M LaFerla; John A Olschowka; M Kerry O'Banion
Journal:  J Neurosci       Date:  2013-03-13       Impact factor: 6.167

10.  Genetic polymorphism of interleukin 1β -511C/T and susceptibility to sporadic Alzheimer's disease: a meta-analysis.

Authors:  Hai Yuan; Qing Xia; Pingping Ge; Shaowei Wu
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.